Inhibrx Biosciences, Inc. (INBX)
USD 12.15
(-1.38%)
USD 12.15
(-1.38%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 210.14 Million USD | 3.99% |
| 2022 | 202.06 Million USD | 186.74% |
| 2021 | 70.47 Million USD | 88.15% |
| 2020 | 37.45 Million USD | -10.25% |
| 2019 | 41.73 Million USD | 339.57% |
| 2018 | 9.49 Million USD | -35.24% |
| 2017 | 14.66 Million USD | -22.51% |
| 2016 | 18.91 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 2.17 Million USD | -98.97% |
| 2024 Q1 | 210.88 Million USD | 0.36% |
| 2023 Q2 | 208.61 Million USD | 2.63% |
| 2023 FY | 210.14 Million USD | 3.99% |
| 2023 Q1 | 203.26 Million USD | 0.59% |
| 2023 Q4 | 210.14 Million USD | 2.15% |
| 2023 Q3 | 205.72 Million USD | -1.39% |
| 2022 Q2 | 175.69 Million USD | 52.19% |
| 2022 FY | 202.06 Million USD | 186.74% |
| 2022 Q4 | 202.06 Million USD | 17.05% |
| 2022 Q3 | 172.63 Million USD | -1.74% |
| 2022 Q1 | 115.44 Million USD | 63.82% |
| 2021 Q1 | 37.29 Million USD | -0.42% |
| 2021 FY | 70.47 Million USD | 88.15% |
| 2021 Q2 | 77.15 Million USD | 106.87% |
| 2021 Q4 | 70.47 Million USD | -8.68% |
| 2021 Q3 | 77.16 Million USD | 0.02% |
| 2020 FY | 37.45 Million USD | -10.25% |
| 2020 Q4 | 37.45 Million USD | 220.23% |
| 2020 Q3 | 11.69 Million USD | 8.5% |
| 2020 Q2 | 10.78 Million USD | 0.0% |
| 2019 FY | 41.73 Million USD | 339.57% |
| 2019 Q4 | 41.73 Million USD | 0.0% |
| 2019 Q2 | 40.42 Million USD | 142.91% |
| 2019 Q1 | 16.64 Million USD | 0.0% |
| 2018 FY | 9.49 Million USD | -35.24% |
| 2017 FY | 14.66 Million USD | -22.51% |
| 2016 FY | 18.91 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -147886.62% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -2644.288% |
| XOMA Corporation | 124.45 Million USD | -68.856% |
| Mesoblast Limited | 118.92 Million USD | -76.703% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 8.312% |
| Aptorum Group Limited | 3.36 Million USD | -6149.738% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -16074.447% |
| HilleVax, Inc. | 51.19 Million USD | -310.488% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -739.154% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -906.218% |
| Precision BioSciences, Inc. | 31.26 Million USD | -572.064% |
| Dyadic International, Inc. | 136.92 Thousand USD | -153367.125% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -132900.633% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -7216.887% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -3752.264% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -98096.729% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -3742.403% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 8.408% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -1591.412% |
| IGM Biosciences, Inc. | 40.5 Million USD | -418.79% |
| Opthea Limited | 200.62 Million USD | -4.741% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -305.873% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -3791.5% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -2041.455% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -3308.613% |
| NextCure, Inc. | 6.6 Million USD | -3081.544% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -33684.564% |
| Ovid Therapeutics Inc. | 46 Million USD | -356.811% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -889.411% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -595.463% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -238.528% |
| Senti Biosciences, Inc. | 37.66 Million USD | -457.906% |
| Apollomics, Inc. | 4.66 Million USD | -4408.496% |
| PureTech Health plc | 25.51 Million USD | -723.695% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -65982.075% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -1519.459% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -148.177% |
| ChromaDex Corporation | 3.27 Million USD | -6312.603% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -101.706% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -451.493% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -100.564% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -102.964% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -107.272% |
| Fortress Biotech, Inc. | 88.59 Million USD | -137.201% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -232.675% |
| Celcuity Inc. | 37.44 Million USD | -461.18% |
| ContextLogic Inc. | 6 Million USD | -3402.35% |
| GH Research PLC | 343 Thousand USD | -61165.598% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -3103.857% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -567848.649% |
| ImmuCell Corporation | 11.96 Million USD | -1655.666% |
| Amarin Corporation plc | 8.73 Million USD | -2305.185% |
| TG Therapeutics, Inc. | 110.79 Million USD | -89.667% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -260.565% |
| Acelyrin, Inc. | 1.19 Million USD | -17499.749% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -643.625% |
| Novavax, Inc. | 280.63 Million USD | 25.119% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -51.148% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 96.375% |
| AnaptysBio, Inc. | 17.81 Million USD | -1079.64% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -3793.663% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -1481.672% |
| AbCellera Biologics Inc. | 77.38 Million USD | -171.57% |
| CorMedix Inc. | 667.63 Thousand USD | -31375.573% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -1818.22% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 92.225% |
| Aptose Biosciences Inc. | 1 Million USD | -20710.037% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -2427591.774% |
| Soligenix, Inc. | 3.49 Million USD | -5913.373% |
| Century Therapeutics, Inc. | 48.17 Million USD | -336.24% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -82.46% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -46538.821% |
| Kura Oncology, Inc. | 17.2 Million USD | -1121.75% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -2942.876% |
| Ardelyx, Inc. | 55.98 Million USD | -275.372% |
| Ainos, Inc. | 5.96 Million USD | -3423.753% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -127.344% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -9674.0% |
| Prothena Corporation plc | 11.83 Million USD | -1675.589% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -1403.8% |
| Autolus Therapeutics plc | 52.96 Million USD | -296.739% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -732.736% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -402.213% |
| Celularity Inc. | 65.41 Million USD | -221.233% |
| Rallybio Corporation | 392 Thousand USD | -53507.398% |
| GRI Bio, Inc. | 14 Thousand USD | -1500907.143% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | 37.88% |
| INmune Bio, Inc. | 10.43 Million USD | -1913.423% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -16.987% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3457.456% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -257173.506% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -25314.83% |
| Humacyte, Inc. | 58.1 Million USD | -261.651% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -263.113% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 56.297% |
| Immunocore Holdings plc | 84.03 Million USD | -150.073% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -11240.583% |
| Verastem, Inc. | 41.55 Million USD | -405.669% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -1747.881% |
| Histogen Inc. | 4.62 Million USD | -4446.538% |
| Surrozen, Inc. | 3.37 Million USD | -6119.029% |
| Blueprint Medicines Corporation | 774.12 Million USD | 72.854% |
| Organovo Holdings, Inc. | 1.39 Million USD | -14974.677% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -8325.862% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -362212.069% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -148.429% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -100436.312% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -4087.744% |
| Summit Therapeutics Inc. | 106.09 Million USD | -98.061% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -90.418% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -129363.334% |
| Turnstone Biologics Corp. | 3.21 Million USD | -6438.301% |
| Pulmatrix, Inc. | 8.75 Million USD | -2299.966% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -84977.328% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -115.293% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -1417.264% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -82.183% |
| Cytokinetics, Incorporated | 755.77 Million USD | 72.195% |
| Exelixis, Inc. | 189.94 Million USD | -10.633% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -586.421% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -89.439% |
| Evogene Ltd. | 1.13 Million USD | -18365.817% |
| Replimune Group, Inc. | 75.86 Million USD | -176.979% |
| PDS Biotechnology Corporation | 23.85 Million USD | -781.035% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -380831.75% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -7442.749% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -261503.675% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -429900.0% |
| BioLineRx Ltd. | 11.59 Million USD | -1712.967% |
| Avid Bioservices, Inc. | 207.83 Million USD | -1.11% |
| Insmed Incorporated | 1.2 Billion USD | 82.546% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -9812.311% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -359.094% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -323193.846% |
| MediWound Ltd. | 6.71 Million USD | -3031.292% |
| MiMedx Group, Inc. | 48.09 Million USD | -336.893% |
| OmniAb, Inc. | 25.56 Million USD | -722.116% |
| Alector, Inc. | 38.91 Million USD | -439.958% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 1.774% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 49.367% |
| Mereo BioPharma Group plc | 5.95 Million USD | -3430.595% |
| Zai Lab Limited | 15.15 Million USD | -1286.978% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 56.077% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -12752.661% |
| Aura Biosciences, Inc. | 19.55 Million USD | -974.505% |
| Immunic, Inc. | 1.33 Million USD | -15652.699% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -666.518% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -562.237% |
| Veracyte, Inc. | 12.63 Million USD | -1563.824% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 67.413% |
| FibroGen, Inc. | 170.45 Million USD | -23.282% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2214.073% |
| Allakos Inc. | 41.46 Million USD | -406.791% |
| scPharmaceuticals Inc. | 40.26 Million USD | -421.843% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -1841.974% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -139066.225% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -12762.526% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -102955.254% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -4859.665% |
| Precigen, Inc. | 7.09 Million USD | -2860.984% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 87.477% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -2771.956% |
| Incyte Corporation | 38.28 Million USD | -448.857% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -69780.684% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -386.809% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -1786.703% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -7442.749% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | 11.939% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -706.9% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -60112.321% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -681.745% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -366.224% |
| Agenus Inc. | 350.24 Million USD | 40.002% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -196493.726% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -14709.091% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -364.544% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -386.787% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -335.715% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -128060.544% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 75.24% |
| UroGen Pharma Ltd. | 100.21 Million USD | -109.692% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -20353.709% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -14.989% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -1480391.757% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -68798.689% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -53507.124% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -2974.484% |
| Chimerix, Inc. | 2.14 Million USD | -9701.353% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -21497.225% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -491.026% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -121598.818% |
| Pluri Inc. | 29.61 Million USD | -609.648% |
| Cue Biopharma, Inc. | 14.69 Million USD | -1330.017% |
| MeiraGTx Holdings plc | 89.26 Million USD | -135.415% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -984166.979% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -4208.817% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -239.935% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -101.872% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -2938.037% |
| NLS Pharmaceutics AG | 1.63 Million USD | -12762.526% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -566.099% |
| Nutriband Inc. | 241.28 Thousand USD | -86992.443% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -3743.808% |
| Vor Biopharma Inc. | 35.66 Million USD | -489.291% |
| Roivant Sciences Ltd. | 499.74 Million USD | 57.951% |
| ProKidney Corp. | 4.41 Million USD | -4661.863% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -17040.375% |
| Daré Bioscience, Inc. | 5.31 Million USD | -3851.397% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 87.922% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -37093.097% |
| Bicycle Therapeutics plc | 44.95 Million USD | -367.437% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -439.931% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -192.647% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -138.949% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1175.437% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -8473.698% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -31032.0% |
| MediciNova, Inc. | 215.92 Thousand USD | -97220.841% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -8322.485% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -16564.261% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -18317.266% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -12.754% |
| Biomea Fusion, Inc. | 10.29 Million USD | -1940.997% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -276.199% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -5753.51% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2193.865% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -1332.356% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -1614.317% |
| bluebird bio, Inc. | 330.32 Million USD | 36.384% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -1580.321% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -12834.03% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 81.467% |
| BioAtla, Inc. | 2.46 Million USD | -8442.317% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -120.92% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -3689.055% |
| DBV Technologies S.A. | 14.38 Million USD | -1361.241% |
| Fortress Biotech, Inc. | 88.59 Million USD | -137.201% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -2032.978% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -1009.919% |
| aTyr Pharma, Inc. | 15.09 Million USD | -1292.123% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -898.389% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -64263.095% |
| Galecto, Inc. | 249 Thousand USD | -84293.976% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -12778.457% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 85.984% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -98.127% |
| Entera Bio Ltd. | 390 Thousand USD | -53782.308% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 48.086% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -3285.003% |
| Xencor, Inc. | 83.43 Million USD | -151.865% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -12356.491% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -4459.362% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -17065.213% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -2134.592% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -128060.544% |
| Portage Biotech Inc. | 47 Thousand USD | -447008.511% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -16564.261% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -8594.29% |
| OncoCyte Corporation | 2.86 Million USD | -7224.538% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -139478.49% |
| Purple Biotech Ltd. | 351 Thousand USD | -59769.231% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -6552.137% |
| Onconetix, Inc. | 9.88 Million USD | -2025.691% |
| MacroGenics, Inc. | 33.97 Million USD | -518.589% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -10231.421% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -3917.224% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -1441.414% |
| Aditxt, Inc. | 18.21 Million USD | -1053.481% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -685.926% |
| Curis, Inc. | 2.79 Million USD | -7421.152% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -9735.994% |
| Adagene Inc. | 22.3 Million USD | -842.046% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1155.998% |
| BeiGene, Ltd. | 930.18 Million USD | 77.409% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -25894.617% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 65.605% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -276401.316% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -8298.921% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -156.217% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -2.052% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -4425.0% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 92.167% |
| ADMA Biologics, Inc. | 141.41 Million USD | -48.596% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -246.888% |
| Clene Inc. | 32.16 Million USD | -553.403% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -8166.758% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -1014.629% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -9473.622% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -314.708% |
| Adicet Bio, Inc. | 20.92 Million USD | -904.306% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -8.773% |
| Absci Corporation | 15.95 Million USD | -1216.92% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -1273.201% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -935.534% |
| Surrozen, Inc. | 3.37 Million USD | -6119.029% |
| Generation Bio Co. | 97.89 Million USD | -114.662% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -63772.644% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -664.566% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -730.663% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -756.251% |
| Invivyd, Inc. | 2.16 Million USD | -9606.282% |
| Cingulate Inc. | 3.13 Million USD | -6602.851% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -293.037% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -5963495.395% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -41852.434% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -3691.106% |
| Jaguar Health, Inc. | 35.86 Million USD | -486.004% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -333457.143% |
| 2seventy bio, Inc. | 256.67 Million USD | 18.129% |
| Clearside Biomedical, Inc. | 43 Million USD | -388.689% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -34749.254% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -267.347% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -3644.391% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -43566.116% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -643.283% |
| Innoviva, Inc. | 449.07 Million USD | 53.206% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -939.324% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -207.989% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1121.963% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -68.734% |
| Evaxion Biotech A/S | 10.86 Million USD | -1833.277% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -152.001% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -180.536% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -3134.929% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -512439.024% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -678.588% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -45091.613% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -666.127% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -1957.583% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -5807.816% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -13413.891% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -16577.857% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -1354.867% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -23094.371% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -306.242% |
| ImmunityBio, Inc. | 883.67 Million USD | 76.22% |
| Korro Bio, Inc. | 33.2 Million USD | -532.821% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -196.073% |
| Kineta, Inc. | 1.31 Million USD | -15856.036% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -89523.45% |
| BioVie Inc. | 6.11 Million USD | -3338.482% |
| Codexis, Inc. | 22.36 Million USD | -839.64% |
| Celularity Inc. | 65.41 Million USD | -221.233% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -54767.102% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -93587.472% |
| Kodiak Sciences Inc. | 181.63 Million USD | -15.696% |
| Cibus, Inc. | 24.62 Million USD | -753.503% |
| Annexon, Inc. | 31.35 Million USD | -570.199% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -8872.716% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 85.543% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -180.054% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -5284.089% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -1204.595% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -88.484% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -356.441% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -554.278% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -21234.112% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -1734.171% |
| Alkermes plc | 290.73 Million USD | 27.72% |
| Arcellx, Inc. | 97.62 Million USD | -115.253% |
| Moolec Science SA | 2.64 Million USD | -7843.971% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -9678.548% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -3228.703% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -692.596% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -6674.371% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -8648.585% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -12025.851% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -261.651% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -637.673% |
| Geron Corporation | 85.89 Million USD | -144.637% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -361.747% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 96.575% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -182228.596% |
| Notable Labs, Ltd. | 2.04 Million USD | -10155.783% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -521.168% |
| Structure Therapeutics Inc. | 5.45 Million USD | -3753.676% |
| IN8bio, Inc. | 4.89 Million USD | -4194.727% |
| 89bio, Inc. | 27.1 Million USD | -675.199% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -52435.25% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -291.266% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -8242.239% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -15605.605% |
| Liquidia Corporation | 3.5 Million USD | -5898.887% |
| Mustang Bio, Inc. | 2.49 Million USD | -8312.37% |
| Immunovant, Inc. | 138 Thousand USD | -152176.087% |
| Vericel Corporation | 88.14 Million USD | -138.409% |
| Quantum-Si incorporated | 15.3 Million USD | -1273.201% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -2309.598% |
| XOMA Corporation | 124.45 Million USD | -68.856% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -76593.796% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -257173.506% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1482.864% |
| Vaxcyte, Inc. | 29.22 Million USD | -619.07% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -1827.369% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -103417.734% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -917.09% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -12612.704% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -16577.857% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -52044.169% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -20262.5% |
| PepGen Inc. | 20.1 Million USD | -945.27% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -36509.93% |
| United Therapeutics Corporation | 700 Million USD | 69.98% |
| Solid Biosciences Inc. | 26.26 Million USD | -700.08% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -21234.112% |
| Immuneering Corporation | 4.46 Million USD | -4608.558% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -207960.396% |
| Belite Bio, Inc | 886 Thousand USD | -23617.946% |
| Pharming Group N.V. | 171.54 Million USD | -22.499% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | 12.302% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -885.144% |
| uniQure N.V. | 138.4 Million USD | -51.826% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1148.61% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -146.0% |
| Altimmune, Inc. | 671 Thousand USD | -31217.586% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1482.864% |
| Peak Bio, Inc. | 10.72 Million USD | -1859.94% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2214.073% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -11928.678% |
| Benitec Biopharma Inc. | 284 Thousand USD | -73893.31% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 52.784% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -72451.727% |
| Compugen Ltd. | 1.35 Million USD | -15454.478% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -99734.671% |
| argenx SE | 20 Million USD | -950.705% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -391.374% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -148.526% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -954.872% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -79.312% |
| PolyPid Ltd. | 11.77 Million USD | -1684.031% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -129.768% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -4926.094% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -35821.538% |
| Instil Bio, Inc. | 86.05 Million USD | -144.197% |
| Elevation Oncology, Inc. | 30.13 Million USD | -597.286% |
| Immunome, Inc. | 1.65 Million USD | -12635.818% |
| Verona Pharma plc | 51.32 Million USD | -309.4% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -2049.12% |
| Shattuck Labs, Inc. | 4.2 Million USD | -4900.976% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -57950.0% |
| Design Therapeutics, Inc. | 3.05 Million USD | -6789.869% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -80106.489% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -1376.954% |
| Achilles Therapeutics plc | 4.61 Million USD | -4453.434% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 43.771% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -598.166% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -5582.764% |
| Beam Therapeutics Inc. | 173.17 Million USD | -21.347% |
| Moolec Science SA | 2.64 Million USD | -7843.971% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -44140.211% |
| AEON Biopharma, Inc. | 278 Thousand USD | -75490.288% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -2891.757% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -62628.657% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -177.004% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -243.89% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -595.618% |
| Athira Pharma, Inc. | 1.58 Million USD | -13158.107% |
| HCW Biologics Inc. | 6.45 Million USD | -3157.103% |
| XOMA Corporation | 124.45 Million USD | -68.856% |
| NeurAxis, Inc. | 224.26 Thousand USD | -93604.183% |
| Lumos Pharma, Inc. | 6.58 Million USD | -3091.207% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -2049.12% |
| 180 Life Sciences Corp. | 1.32 Million USD | -15818.941% |
| Nektar Therapeutics | 230.4 Million USD | 8.793% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -954.872% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1130.325% |
| Arvinas, Inc. | 3.4 Million USD | -6080.618% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -13413.891% |
| Palisade Bio, Inc. | 369 Thousand USD | -56848.78% |
| Nutriband Inc. | 241.28 Thousand USD | -86992.443% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -12778.457% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -25340.799% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -50536.386% |
| Merus N.V. | 12.16 Million USD | -1627.849% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -63.626% |
| Neurogene Inc. | 16.25 Million USD | -1192.778% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 31.804% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -636.278% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -1421.218% |
| Rezolute, Inc. | 2.22 Million USD | -9331.822% |
| Clene Inc. | 32.16 Million USD | -553.403% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -119944.215% |
| BeyondSpring Inc. | 3.99 Million USD | -5160.1% |
| Synlogic, Inc. | 17.27 Million USD | -1116.446% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -16064.692% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -600302.857% |
| Peak Bio, Inc. | 10.72 Million USD | -1859.94% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -304.717% |
| Krystal Biotech, Inc. | 8.09 Million USD | -2496.257% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -18.713% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -2877.767% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -153743.507% |
| MannKind Corporation | 382.37 Million USD | 45.044% |
| Ikena Oncology, Inc. | 10.73 Million USD | -1856.985% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -51279.218% |
| Gossamer Bio, Inc. | 212.46 Million USD | 1.093% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -120670.69% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2193.865% |
| Legend Biotech Corporation | 328.67 Million USD | 36.064% |
| Mural Oncology plc | 15 Million USD | -1300.1% |
| Disc Medicine, Inc. | 2.1 Million USD | -9901.951% |
| Champions Oncology, Inc. | 7.43 Million USD | -2728.277% |
| REGENXBIO Inc. | 89.29 Million USD | -135.347% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -24486.608% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -37901.418% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -3781.437% |
| Vaxart, Inc. | 26.51 Million USD | -692.566% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -1242.123% |
| Cellectis S.A. | 92.85 Million USD | -126.316% |
| Longeveron Inc. | 2.04 Million USD | -10195.982% |
| Repare Therapeutics Inc. | 3.41 Million USD | -6062.493% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 84.956% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -351.024% |
| Revolution Medicines, Inc. | 87.94 Million USD | -138.949% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -121368.786% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -5215.988% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -66190.536% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -119980.571% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 74.005% |
| Denali Therapeutics Inc. | 52.24 Million USD | -302.253% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -1358.759% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -15194.105% |
| Cingulate Inc. | 3.13 Million USD | -6602.851% |
| Passage Bio, Inc. | 26.29 Million USD | -699.198% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -3052.903% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -51405.147% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -23405.705% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -922.037% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -8473.261% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -6628.818% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -25811.344% |
| OmniAb, Inc. | 25.56 Million USD | -722.116% |
| Anew Medical, Inc. | 1.6 Million USD | -12992.897% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -610.347% |
| Lipocine Inc. | 17.16 Thousand USD | -1224069.871% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -1705.645% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -506.853% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3457.456% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -267.553% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -103417.734% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -3968.558% |
| Ocugen, Inc. | 6.94 Million USD | -2927.532% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1387.303% |
| Q32 Bio Inc. | 1.31 Million USD | -15843.93% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -31170.982% |
| Alumis Inc. Common Stock | 32.58 Million USD | -545.0% |
| Equillium, Inc. | 824 Thousand USD | -25402.549% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -2214.583% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -69759.311% |
| Dominari Holdings Inc. | 3.02 Million USD | -6839.927% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -222302.024% |
| vTv Therapeutics Inc. | 529 Thousand USD | -39624.197% |
| Bio-Techne Corporation | 419.53 Million USD | 49.911% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -191.879% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -8.563% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1144.321% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -823.21% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -3368.818% |
| Nkarta, Inc. | 88.33 Million USD | -137.88% |
| BioCardia, Inc. | 1.31 Million USD | -15880.304% |
| Iterum Therapeutics plc | 19.5 Million USD | -977.149% |